IDXX IDEXX Laboratories, Inc.

$504.70▼ -0.36% Healthcare Other
After hours $504.70▲ +0.00% Sep 11, 7:30 PM ET
Volume 401.6K Avg Volume (10D) 508.3K
Key Metrics & Fundamentals
Market Cap
$39.76B
P/E Ratio
35.5
Div Yield
–%
52W Range
500.61 - 769.98
% vs 50 MA
-9.23%
% vs 200 MA
-16.37%
RSI-14
31.6
MACD Histogram
-4.8200
Beta (1Y vs SPY)
0.91
Free Cash Flow
$320.62M
Gross Rev
$1.22B
Gross Profit
$779.09M
EBITDA
$467.22M
COGS
$437.50M
Operating Exp
$353.52M
Operating Income
$425.57M
EBIT
$425.57M
Pretax Income
$417.22M
Net Income
$338.41M
EPS (Diluted)
4.27
Price & Volume History
Loading chart…
Recent News
Pfizer Stock Or Zoetis: Is The Comeback Worth Paying Up For?
Trefis · Sep 10, 2026 5:05 PM
Insider Alert: IDEXX Director Lawrence Kingsley Sells $1.2 Million of Stock
Motley Fool · Sep 10, 2026 11:20 AM
Is IDEXX Laboratories Stock Underperforming the Dow?
Barchart · Sep 10, 2026 9:21 AM
Idexx (IDXX) Down 7.8% Since Last Earnings Report: Can It Rebound?
Zacks · Sep 3, 2026 3:30 PM
IDEXX Laboratories to Participate in Morgan Stanley 24th Annual Global Healthcare Conference
Business Wire · Aug 31, 2026 6:00 PM
Are Wall Street Analysts Predicting IDEXX Laboratories Stock Will Climb or Sink?
Barchart · Aug 26, 2026 12:09 PM
Is it a Prudent Move to Retain IDEXX Stock in Your Portfolio Now?
Zacks · Aug 21, 2026 1:54 PM
Rationale Behind Baron Focused Growth Fund’s IDEXX Laboratories (IDXX) Holding
Insider Monkey · Aug 20, 2026 3:42 PM
IDXX Raises 2026 EPS Outlook as Diagnostic Growth and Margins Improve
Zacks · Aug 20, 2026 3:37 PM
Is IDXX Worth Buying as Growth Strength Meets a Premium Valuation?
Zacks · Aug 19, 2026 2:08 PM
Financial Overview - Income Statement Quarterly

See IDXX's money flow as a full page

Social Sentiment
Avg +0.50 · 1 posts
I dug into the filings for 5 "boring" companies and now I think boring is underpriced
r/stocks · Mar 7, 2026
The comment indicates potential growth due to shifts in the vet diagnostics industry and consolidation trends.
positive +0.50
AI Analysis

Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.

Not financial advice. All data, scores, charts, and analysis on this site are provided for informational and educational purposes only and do not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. See our Legal Notice for full details.
An unhandled error has occurred. Reload 🗙